Beone Medicines Ltd
(ONC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 618,299 | 727,481 | 239,602 | 87,514 | 17,869 |
| Marketable Securities | 364,728 | 1,068,509 | 597,914 | 280,660 | 82,617 |
| Receivables | 70,878 | 41,056 | 29,428 | N/A | N/A |
| Inventories | 28,553 | 16,242 | 10,930 | N/A | N/A |
| TOTAL | $1,172,696 | $1,943,842 | $913,497 | $374,399 | $106,269 |
| Non-Current Assets | |||||
| PPE Net | 242,402 | 157,061 | 62,568 | 25,977 | 6,612 |
| Intangibles | 5,846 | 52,230 | 19,824 | 0 | 0 |
| Other Non-Current Assets | 191,345 | 96,551 | 50,590 | 5,437 | 3,883 |
| TOTAL | $439,593 | $305,842 | $132,982 | $31,414 | $10,495 |
| Total Assets | $1,612,289 | $2,249,684 | $1,046,479 | $405,813 | $116,764 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 8,727 | 9,222 | N/A | N/A |
| Accounts payable and accrued liabilities | 122,488 | 113,283 | 69,779 | 11,957 | 8,980 |
| Accrued Expenses | 163,556 | 100,414 | 49,598 | 22,297 | 8,351 |
| Other current liabilities | N/A | N/A | N/A | N/A | 3,243 |
| TOTAL | $310,312 | $246,452 | $149,988 | $35,058 | $35,172 |
| Non-Current Liabilities | |||||
| Long Term Debt | 240,695 | 189,673 | 155,493 | 17,284 | 6,188 |
| Deferred Revenues | N/A | 18,140 | 12,233 | N/A | N/A |
| Other Non-Current Liabilities | 74,345 | 49,037 | 32,153 | 564 | 105 |
| TOTAL | $323,622 | $249,585 | $212,260 | $17,848 | $7,273 |
| Total Liabilities | $633,934 | $496,037 | $362,248 | $52,906 | $42,445 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 65,133 | N/A | N/A | N/A | N/A |
| Common Shares | 79 | 77 | 59 | 52 | 12 |
| Retained earnings | -1,955,843 | -1,007,215 | -330,517 | -237,412 | -118,195 |
| Other shareholders' equity | 8,149 | 15,971 | 13,942 | -946 | 174,275 |
| TOTAL | $978,355 | $1,753,647 | $684,231 | $352,907 | $74,319 |
| Total Liabilities And Equity | $1,612,289 | $2,249,684 | $1,046,479 | $405,813 | $116,764 |